605
Views
14
CrossRef citations to date
0
Altmetric
Letter

Acute lymphoblastic leukemia developing during maintenance therapy with lenalidomide in a patient with multiple myeloma

, , &
Pages 2753-2755 | Received 29 Oct 2012, Accepted 11 Mar 2013, Published online: 15 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

I. Arribas, C. Maluquer, H. Pomares, I. Carro, C. Baca, A. Bosch, C. E. Arévalo, C. Montané, J. Ribes-Amorós, L. Zamora, I. Granada, E. Gamundi, M. Arnan & A. Sureda. (2023) B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature. Leukemia & Lymphoma 0:0, pages 1-5.
Read now
Alicja Sadowska-Klasa, Mary Abba, Justyna Gajkowska-Kulik & Jan Maciej Zaucha. (2022) Therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma – diagnostic and therapeutic dilemma. Acta Oncologica 61:9, pages 1126-1131.
Read now

Articles from other publishers (12)

Junru Liu, Beihui Huang, Jingli Gu & Juan Li. (2023) Clinical Characteristics and Prognosis of Secondary Acute Lymphoblastic Leukemia in Patients with Multiple Myeloma during Long-Term Thalidomide Maintenance. Journal of Personalized Medicine 13:3, pages 412.
Crossref
Erica K. Barnell, Zachary L. Skidmore, Kenneth F. Newcomer, Monique Chavez, Katie M. Campbell, Kelsy C. Cotto, Nicholas C. Spies, Marianna B. Ruzinova, Tianjiao Wang, Brooj Abro, Friederike Kreisel, Bijal A. Parikh, Eric J. Duncavage, John L. Frater, Yi-Shan Lee, Anjum Hassan, Justin A. King, Daniel R. Kohnen, Mark A. Fiala, John S. Welch, Geoffrey L. Uy, Kiran Vij, Ravi Vij, Malachi Griffith, Obi L. Griffith & Lukas D. Wartman. (2023) Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Advances 7:2, pages 236-245.
Crossref
Benjamin Puliafito, David Oveisi, Christina Fanous & Monica El-Masry. (2022) Secondary B-cell acute lymphoblastic leukaemia in a patient with multiple myeloma. BMJ Case Reports 15:6, pages e249637.
Crossref
Michael E. Kallen, Rima Koka, Zeba N. Singh, Yi Ning, Mehmet H. Kocoglu, Ashraf Z. Badros, Sandrine Niyongere, Vu H. Duong, Ashkan Emadi & Maria R. Baer. (2022) Therapy-related B-lymphoblastic leukemia after multiple myeloma. Leukemia Research Reports 18, pages 100358.
Crossref
Christina Poh, Theresa Keegan & Aaron Seth Rosenberg. (2021) Second primary malignancies in multiple myeloma: A review. Blood Reviews 46, pages 100757.
Crossref
Sharon Koorse Germans, Ozlem Kulak, Prasad Koduru, Dwight Oliver, Jeffery Gagan, Prapti Patel, Larry D AndersonJrJr, Franklin S Fuda, Weina Chen & Jesse Manuel Jaso. (2020) Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma—A Unique Entity. American Journal of Clinical Pathology 154:6, pages 816-827.
Crossref
Ryan B. Sinit, Dick G. Hwang, Prakash Vishnu, Jess F. Peterson & David M. Aboulafia. (2019) B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review. BMC Cancer 19:1.
Crossref
Abdullah M. Khan, Jameel Muzaffar, Hermant Murthy, John R. Wingard & Jan S. Moreb. (2018) Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features. Case Reports in Hematology 2018, pages 1-5.
Crossref
Ahmad Alhuraiji, Kiran Naqvi, Yang O. Huh, Coty Ho, Srdan Verstovsek & Prithviraj Bose. (2018) Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure. Clinical Case Reports 6:1, pages 155-161.
Crossref
D. Kurant, S.I. Fisher, W. Tang & N.S. Aguilera. (2017) B-lymphoblastic leukemia/lymphoma arising in treated plasma cell myeloma: A rare second malignancy. Human Pathology: Case Reports 10, pages 60-63.
Crossref
Marisela Tan, Richard Fong, Mimi Lo & Rebecca Young. (2017) Lenalidomide and secondary acute lymphoblastic leukemia: a case series. Hematological Oncology 35:1, pages 130-134.
Crossref
. (2014) Lenalidomide. Reactions Weekly 1484:1, pages 21-21.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.